2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Instant NanoBiosensors Co., Ltd

Biomedical EcoSystem development office in Taiwan, BEST

July 22nd (Wed.) 19:30 - 21:00 Entrepreneur Pitch 1

Instant NanoBiosensors Co., Ltd

Company Info

Name /Instant NanoBiosensors Co., Ltd

Address /2F., No. 459, Chongyang Rd., Nangang Dist, Taipei, Taiwan

Website /www.instantnano.com

Presenter

Name /Tony Chung

Title /CEO

Email /tonychung@instantnano.com

Telephone /(Work) 02-26538655

Fax /02-26536955

Mobile /0961-094113

Company Type

Device

About the Company

Instant NanoBiosensors Corporation (INB) was founded in 2016 with its headquarters located in Taipei, Taiwan. At INB, we are devoted to the research and development of light-responsive point-of-care (POC) biomarker analyzers based on FOPPRTM (fiber optic particle plasmon resonance) technology with a focus on easy operation, instant and accurate results, and device portability.

We are the FIRST in the world to provide a biomarker analyzing technology with a wide linear dynamic range (~5 orders), ultrasensitivity (~fg/mL), and high specificity. Through combining novel biomarkers with our cutting-edge biosensing platform, we aspire to revolutionize traditional immunoassays and analyses for a more efficient healthcare ecosystem.

Brief Description of main products or services

In response to the needs of clinical medicine and detection, development for timely diagnosis and rapid screening has become a must-win battle in the area of biomedicine, and the Light-Sensing Biomarker Analyzer (Model No. INB D-200) developed by Instant NanoBiosensors which adopts the world’s first Fiber Optic Particle Plasmon Resonance (FOPPR) technology can shorten the time consumed in detecting biomarker, such as 、TNF-α、PCT、cTnI, at the laboratory from three hours and to just several minutes, thus can complete on-site detection to assist the medical personnel in speeding up their diagnosis and make timely medical decisions to avoid missing out on the best timing for treating the patients and damage and waste of medical resources. In the future, prognostic tracing for the patients can be done more effectively through such portable device (Light-Sensing POCT, Model No. INB D1) ) while transmitting data simultaneously to the back-end diagnosis cloud platform, therefore may realize the vision of “immediate care” to assist the patients in receiving further diagnosis and achieving the goal of self-health management.

Contact Person

Name /Tony Chung

Email /tonychung@instantnano.com

Phone /02-26538655